THE Zambia Medicines and Medical Supplies Agency (ZAMMSA) says Missionpharma will reimburse the extra costs which the agency has incurred due to the defective Erythromicin which they supplied if the third test also fails. And ZAMMSA says there are some CT scans and hospital furniture from China which are currently being distributed. Meanwhile, the agency says cancer treatment medicines are now just below 50 percent capacity. Speaking when he featured on Phoenix FM’s Let the People Talk Programme, Tuesday, Acting ZAMMSA Director General Victor Nyasulu said every extra cost they had incurred would be on Missionpharma’s account. “The contractual obligation coming from the part of Missionpharma…by the way everything we are doing now which is causing us to incur a...